Crispr Therapeutics Ag earnings were -$366.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CRSP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$37.3M, down 56.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRSP reported annual earnings of -$366.3M, with 138.4% growth. The next CRSP earnings date is May 30, 2025.
Crispr Therapeutics Ag Earnings Reports & History FAQ
What were Crispr Therapeutics Ag's earnings last quarter?
On CRSP's earnings call on Invalid Date, Crispr Therapeutics Ag (NASDAQ: CRSP) reported Q4 2024 earnings per share (EPS) of -$0.42, up 137.17% year over year. Total CRSP earnings for the quarter were -$37.31 million. In the same quarter last year, Crispr Therapeutics Ag's earnings per share (EPS) was $1.13.
The next CRSP earnings call is Invalid Date. Add CRSP to your watchlist to be reminded of Crispr Therapeutics Ag's next earnings date.
What was CRSP's earnings growth in the past year?
As of Crispr Therapeutics Ag's earnings date in Invalid Date, Crispr Therapeutics Ag's earnings has grown year over year. CRSP earnings in the past year totalled -$366.25 million.
Is Crispr Therapeutics Ag profitable or losing money?
As of the last Crispr Therapeutics Ag earnings report, Crispr Therapeutics Ag is currently losing money. Crispr Therapeutics Ag's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$366.25 million, a 138.43% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.